Real-world evaluation of an acceptance and commitment therapy-based group programme for breast cancer survivors with fear of cancer recurrence

被引:2
|
作者
Sinclair, Fiona [1 ]
Gillanders, David [2 ]
Rooney, Natalie [3 ]
Bonathan, Christine [1 ]
Hendry, Kirsty [4 ]
McLoone, Philip [4 ]
Hewitt, Christopher [5 ]
机构
[1] NHS Greater Glasgow & Clyde, Glasgow, Scotland
[2] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Scotland
[3] Maggies Forth Valley, Larbert, Scotland
[4] Univ Glasgow, Sch Hlth & Wellbeing, Glasgow, Scotland
[5] NHS Lothian, Edinburgh, Scotland
关键词
Breast cancer; Fear of cancer recurrence; Acceptance and commitment therapy; Patient support; Group support; COMPREHENSIVE ASSESSMENT; PREVALENCE; VALIDATION; VALIDITY;
D O I
10.1007/s00520-023-08179-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To evaluate the effectiveness and acceptability of a 6-week acceptance and commitment therapy (ACT)-based group programme on participants' fear of cancer recurrence (FCR), quality of life (QoL), psychological distress and psychological flexibility at the end of the programme and 12-week follow-up.Methods A one-group, post-test service evaluation of a real-world psychological programme was carried out to evaluate collected outcome measures and attendance for a total of 21 groups facilitated between 2017 and 2019. Participants were breast cancer survivors who attended a 6-week group programme led by NHS clinicians. Descriptive statistics and repeated measures ANOVA analyses were carried out for each outcome measure. Attendance levels were examined to assess acceptability.Results A total of 97 group participants who had completed curative treatment for breast cancer took part. Of whom, 89% completed at least 4 of the 6 weekly group sessions and 76% attended the 12-week follow-up session. Eighty-four (87%) participants returned outcome measures at all three time points relative to group participation (T1 = pre, T2 = post T3 = 12-week follow-up). Group participants were female, mean age 51.9 years. FCR was highest at T1 (mean 25.2, SD 4.7), reduced T2 (mean 21.2, SD 5.4) and further lowered T3 (mean 19.5, SD 6.2). This difference was statistically significant (p < 0.001). QoL was lowest at T1 (mean 62.4, SD 15.7), increased T2 (mean 71.7, SD 18.1) and further increased at T3 (mean 75.9, SD 17.5). This difference was statistically significant (p < 0.001). Psychological distress measures were shown to reduce, and psychological flexibility increased.Conclusions This real-world evaluation of an ACT-based group programme led to improvements in FCR, QoL, psychological distress and psychological flexibility in this population. This evaluation provides basis for further investigation to determine if these results can be replicated by controlled research design across diverse populations.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] TRASTUZUMAB THERAPY FOR EARLY BREAST CANCER IN THE REAL-WORLD
    Marla, S.
    Cooke, T. G.
    Roxburgh, P.
    Burton, P.
    Mallon, E.
    Stallard, S.
    Canney, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 85 - 86
  • [22] Interpretation Bias in Breast Cancer Survivors Experiencing Fear of Cancer Recurrence
    Tuman, Malwina
    Roberts, Kailey E.
    Corner, Geoffrey
    Beard, Courtney
    Fadalla, Carol
    Coats, Taylor
    Slivjak, Elizabeth
    Schofield, Elizabeth
    Lichtenthal, Wendy G.
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [23] FEAR OF CANCER RECURRENCE AND CORTISOL LEVELS IN PARTNERS OF BREAST CANCER SURVIVORS
    Fenech, Alyssa L.
    Soriano, Emily C.
    Asok, Arun
    Siegel, Scott D.
    Laurenceau, Jean-Philippe
    ANNALS OF BEHAVIORAL MEDICINE, 2023, 57 : S226 - S226
  • [24] The Cancer Worry Scale Detecting Fear of Recurrence in Breast Cancer Survivors
    Custers, Jose A. E.
    van den Berg, Sanne W.
    van Laarhoven, Hanneke W. M.
    Bleiker, Eveline M. A.
    Gielissen, Marieke F. M.
    Prins, Judith B.
    CANCER NURSING, 2014, 37 (01) : E44 - E50
  • [25] Factors associated with fear of cancer recurrence in breast and colorectal cancer survivors
    Nahm, Sharon
    Blinman, Prunella
    Butler, Sue
    Tan, Sim Yee
    Vardy, Janette
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 165 - 165
  • [26] Finding your direction with COMPASS: Group acceptance and commitment therapy for cancer patients and survivors
    Shumay, Dianne
    PSYCHO-ONCOLOGY, 2017, 26 : 12 - 13
  • [27] The Development and Process Evaluation of a 3-Day Acceptance and Commitment Therapy Group Program for Adolescent Cancer Survivors
    Clarke, Kristina
    Patterson, Pandora
    McDonald, Fiona E. J.
    Wakefield, Claire E.
    Sansom-Daly, Ursula
    Zebrack, Brad
    CHILD & YOUTH CARE FORUM, 2021, 50 (02) : 229 - 246
  • [28] Effectiveness of Group Training Based on Acceptance and Commitment Therapy on Anxiety and Depression of Women with Breast Cancer
    Mohabbat-Bahar, Sahar
    Maleki-Rizi, Fatemeh
    Akbari, Mohammad Esmaeil
    Moradi-Joo, Mohammad
    IRANIAN JOURNAL OF CANCER PREVENTION, 2015, 8 (02) : 71 - 76
  • [29] A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression
    Alimolk, Fatemeh Hassani
    McDonald, Fiona Elizabeth Jean
    Asghari-Jafarabadi, Mohammad
    Ahmadi, Farzane
    Zenoozian, Saeedeh
    Lashkari, Marzieh
    Patterson, Pandora
    PSYCHO-ONCOLOGY, 2024, 33 (04)
  • [30] Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors
    J. W. Ankersmid
    F. K. Lansink Rotgerink
    L. J. A. Strobbe
    C.F. van Uden-Kraan
    S. Siesling
    C. H. C. Drossaert
    Breast Cancer Research and Treatment, 2022, 195 : 117 - 125